Literature DB >> 1693670

Silver colloid staining technique for analysis of glioma malignancy.

K Kajiwara1, T Nishizaki, T Orita, H Nakayama, H Aoki, H Ito.   

Abstract

A silver colloid staining technique for identifying nucleolar organizer region-associated proteins (Ag-NOR's) was applied to 51 human gliomas. These comprised 20 glioblastomas multiforme, 15 anaplastic astrocytomas, and 16 astrocytomas, in which the mean numbers of Ag-NOR's per cell (+/- standard error of the mean) were 2.51 +/- 0.12, 2.01 +/- 0.10, and 1.76 +/- 0.06, respectively. Significant differences among these were recognized, and the mean number of Ag-NOR's paralleled the degree of histopathological malignancy. In 16 cases, studies were performed of the number of Ag-NOR's and the S-phase fraction by in vitro labeling using antibromodeoxyuridine monoclonal antibody. A linear relationship was demonstrated between these two factors (r = 0.857, p less than 0.001), although some scatter was seen. In 32 adult patients, the correlation between the number of Ag-NOR's and the prognosis was estimated. The results demonstrated that the group containing patients with less than 1.80 Ag-NOR's per cell had a better prognosis than the group with 1.80 Ag-NOR's or more. Thus, the number of Ag-NOR's reflected the degree of histopathological malignancy, S-phase fraction, and prognosis. Silver colloid staining for Ag-NOR's is a simple, rapid, and reproducible method for estimating the proliferative potential of human gliomas without requiring a complicated technique.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1693670     DOI: 10.3171/jns.1990.73.1.0113

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  10 in total

1.  Histochemical study of pituitary adenomas with Ki-67 and anti-DNA polymerase alpha monoclonal antibodies, bromodeoxyuridine labeling, and nucleolar organizer region counts.

Authors:  M Shibuya; F Saito; T Miwa; R L Davis; C B Wilson; T Hoshino
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

2.  Rapid detection of proliferating potential in human brain tumors by nucleolar organizer region staining on squash preparations.

Authors:  A Hara; N Sakai; H Yamada; N Yoshimi; T Tanaka; H Mori
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

3.  A combined staining method for argyrophilic nucleolar organizer regions and for glial fibrillary acidic protein in astrocytes of human brain.

Authors:  S Fushiki; C Kinoshita; A Nagata; Y Tsutsumi; Y Nishizawa
Journal:  Histochem J       Date:  1996-07

4.  Invasive meningioma: a tumour with high proliferating and "recurrence" potential.

Authors:  T Suwa; N Kawano; H Oka; H Ito; T Kameya
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

Review 5.  Techniques to assess the proliferative potential of brain tumors.

Authors:  Alfredo Quiñones-Hinojosa; Nader Sanai; Justin S Smith; Michael W McDermott
Journal:  J Neurooncol       Date:  2005-08       Impact factor: 4.130

6.  Regional differences in bromodeoxyuridine uptake, expression of Ki-67 protein, and nucleolar organizer region counts in glioblastoma multiforme.

Authors:  K Onda; R L Davis; C B Wilson; T Hoshino
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

7.  Clinical evaluation of DNA index in human brain tumors.

Authors:  T Nishizaki; N Ohshita; Y Nagatsugu; T Orita; H Ito; K Sasaki
Journal:  J Neurooncol       Date:  1993-07       Impact factor: 4.130

8.  A correlative study of in vivo and in vitro labeling index using bromodeoxyuridine in human brain tumors.

Authors:  K Kharbanda; A K Dinda; C Sarkar; A K Karak; R Dhir; M Mathur; S Roy
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

9.  A correlation of argyrophilic nucleolar organizer regions with prognoses in patients with maxillary sinus squamous cell carcinoma.

Authors:  M Miyaguchi; T Kawahara; S Sakai; H Kuwabara; H Sakamoto
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

10.  MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor.

Authors:  P Korkolopoulou; P Christodoulou; K Kouzelis; M Hadjiyannakis; A Priftis; G Stamoulis; A Seretis; E Thomas-Tsagli
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.